UBUS:XETRA:XETRA-UBS (Irl) ETF plc - Factor MSCI USA Prime Value UCITS ETF (USD) A-dis (EUR)

ETF | Others |

Last Closing

USD 31.855

Change

-0.09 (-0.28)%

Market Cap

USD 0.49B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.18 (-0.35%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.37%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.10 (-0.37%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.10 (-0.34%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.08 (+0.33%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.36 (-0.24%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.09%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.19 (-0.37%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.02 (+0.19%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.04 (-0.18%)

USD 79.79B

ETFs Containing UBUS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.72% 52% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.72% 51% F 53% F
Trailing 12 Months  
Capital Gain 12.80% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.80% 57% F 59% D-
Trailing 5 Years  
Capital Gain 61.24% 79% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.24% 78% C+ 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 12.25% 81% B- 79% B-
Dividend Return 12.99% 84% B 79% B-
Total Return N/A 75% C 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 15.58% 34% F 46% F
Risk Adjusted Return 83.38% 92% A 92% A
Market Capitalization 0.49B 67% D+ 59% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.